scholarly journals Production of Lysophosphatidic Acids by Lysophospholipase D in Human Follicular Fluids of In Vitro Fertilization Patients1

1999 ◽  
Vol 61 (1) ◽  
pp. 195-199 ◽  
Author(s):  
Akira Tokumura ◽  
Maki Miyake ◽  
Yuko Nishioka ◽  
Shuji Yamano ◽  
Toshihiro Aono ◽  
...  
Keyword(s):  
In Vitro Fertilization ◽  
Vitro Fertilization ◽  
Lysophospholipase D ◽  
Follicular Fluids

scholarly journals Inhibin A and B levels in serum and follicular fluids of women with various reproductive failures undergoing in vitro fertilization

2015 ◽  
Vol 86 (10) ◽  
pp. 726-730 ◽  
Author(s):  
Katarína Babčová ◽  
Zdenka Ulčová-Gallová ◽  
David Rumpík ◽  
Zdenka Mičanová ◽  
Katarína Bibková
Keyword(s):  
In Vitro Fertilization ◽  
Inhibin A ◽  
Vitro Fertilization ◽  
Follicular Fluids

Significant differences in capillary electrophoretic patterns of follicular fluids and sera from women pre-treated for in vitro fertilization

2002 ◽  
Vol 53 (1-3) ◽  
pp. 151-156 ◽  
Author(s):  
Melinda Rezeli ◽  
Bernadett Világhy ◽  
Ferenc Kilár ◽  
Katalin Kanyó ◽  
Béla Török ◽  
...  
Keyword(s):  
In Vitro Fertilization ◽  
Vitro Fertilization ◽  
Electrophoretic Patterns ◽  
Capillary Electrophoretic ◽  
Follicular Fluids

scholarly journals The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis

2019 ◽  
Vol 12 (1) ◽  
Author(s):  
Hiroshi Tamura ◽  
Hiroaki Yoshida ◽  
Hiroyuki Kikuchi ◽  
Mai Josaki ◽  
Yumiko Mihara ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
In Vitro Fertilization ◽  
Clinical Outcome ◽  
Control Group ◽  
Vitro Fertilization ◽  
Infertile Women ◽  
Significant Difference ◽  
Ivf Et ◽  
Follicular Fluids

Abstract Background Endometriosis is considered to be the most intractable cause of female infertility. Administering any type of treatment for endometriosis before in vitro fertilization and embryo transfer (IVF-ET) is an important strategy for improving the IVF-ET outcomes for infertile women with endometriosis. In fact, treatment with a gonadotropin-releasing hormone (GnRH) agonist just before IVF-ET has been reported to improve the clinical outcome in endometriosis patients. However, the benefit of Dienogest (DNG), a synthetic progestin, treatment just before IVF-ET remains unclear. Methods Sixty-eight infertile women with Stage III or IV endometriosis (ovarian endometrial cyst < 4 cm) were recruited for this study. The subjects were divided into 2 groups: a DNG group (n = 33) and a control group (n = 35). DNG was administered orally every day for 12 weeks prior to the conventional IVF-ET cycle in the DNG group. Standard controlled ovarian hyperstimulation with the GnRH agonist long protocol was performed in the control group. The numbers of mature follicles and retrieved oocytes, fertilization rates, implantation rates, and clinical pregnancy rate were compared between the two groups. In addition, the concentrations of inflammatory cytokines, oxidative stress markers, and antioxidants in follicular fluids were also measured. Results The numbers of growing follicles, retrieved oocytes, fertilized oocytes, and blastocysts were significantly lower in the DNG group than in the control group. The fertilization and blastocyst rates were also lower in the DNG group than in the control group. Although there was no significant difference in the implantation rate between the groups, the cumulative pregnancy rate and live birth rate were lower in the DNG group than in the control group. There was no significant difference in the abortion rate. Our results failed to show that DNG reduces the inflammatory cytokine levels and oxidative stress in follicular fluids. Conclusions Administering DNG treatment just before IVF-ET did not provide any benefits to improve the clinical outcomes for infertile women with endometriosis.

Sign in / Sign up

Export Citation Format

Share Document